BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8797597)

  • 21. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
    Catling AD; Wyke JA; Frame MC
    Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).
    Schuringa JJ; Timmer H; Luttickhuizen D; Vellenga E; Kruijer W
    Cytokine; 2001 Apr; 14(2):78-87. PubMed ID: 11356008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
    Vial E; Perez S; Castellazzi M
    Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A; Shealy YF; Hill DL; Zhang X
    Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-Jun.
    Schroen DJ; Brinckerhoff CE
    J Cell Physiol; 1996 Nov; 169(2):320-32. PubMed ID: 8908199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A short region containing an AP-1 binding site is essential for transforming growth factor-beta-induced c-jun gene expression in osteoblastic cells.
    Hata S; Shimizu T; Fujimoto M
    IUBMB Life; 2000 Mar; 49(3):229-34. PubMed ID: 10868915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells.
    Yukimasa N; Isobe K; Nagai H; Takuwa Y; Nakai T
    Neuropeptides; 1999 Dec; 33(6):475-82. PubMed ID: 10657527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
    Zhang Y; Feng XH; Derynck R
    Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The avian cellular homolog of the oncogene jun.
    Nishimura T; Vogt PK
    Oncogene; 1988 Dec; 3(6):659-63. PubMed ID: 2577867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
    Morgan IM; Asano M; Håvarstein LS; Ishikawa H; Hiiragi T; Ito Y; Vogt PK
    Oncogene; 1993 May; 8(5):1135-40. PubMed ID: 8479738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner.
    Angel P; Smeal T; Meek J; Karin M
    New Biol; 1989 Oct; 1(1):35-43. PubMed ID: 2518690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. v-Rel activates the proto-oncogene c-Jun promoter: a correlation with its transforming activity.
    Fujii M; Minamino T; Nomura M; Miyamoto K; Tanaka J; Seiki M
    Leukemia; 1997 Apr; 11 Suppl 3():402-4. PubMed ID: 9209405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
    Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
    Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimeras of herpes simplex viral VP16 and jun are oncogenic.
    Schuur ER; Parker EJ; Vogt PK
    Cell Growth Differ; 1993 Sep; 4(9):761-8. PubMed ID: 8241024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of a phosphorylation site in the DNA-binding domain is required for redox-independent transactivation of AP1-dependent genes by v-Jun.
    Oehler T; Pintzas A; Stumm S; Darling A; Gillespie D; Angel P
    Oncogene; 1993 May; 8(5):1141-7. PubMed ID: 8479739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AP-1 activity during normal human keratinocyte differentiation: evidence for a cytosolic modulator of AP-1/DNA binding.
    Briata P; D'Anna F; Franzi AT; Gherzi R
    Exp Cell Res; 1993 Jan; 204(1):136-46. PubMed ID: 8416791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible roles of the 3'-flanking sequences of the human activin beta A subunit gene in its expression.
    Tanimoto K; Murakami K; Fukamizu A
    Arch Biochem Biophys; 1993 May; 302(2):409-16. PubMed ID: 8489245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun.
    Hagmeyer BM; König H; Herr I; Offringa R; Zantema A; van der Eb A; Herrlich P; Angel P
    EMBO J; 1993 Sep; 12(9):3559-72. PubMed ID: 8253081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oncogenicity of jun.
    Vogt PK; Bos TJ; Mitsunobu F; Nishimura T; Monteclaro FS; Su HY
    Princess Takamatsu Symp; 1989; 20():127-34. PubMed ID: 2562177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.